Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

A Method of Correcting for the Effect of Temperature on Low-Contrast Penetration Measurement in Urethane Phantoms.

Peake E, Warrington S, Dudley NJ, Morgan PS, Gibson NM.

Ultrasound Med Biol. 2019 Jun;45(6):1483-1488. doi: 10.1016/j.ultrasmedbio.2019.02.012. Epub 2019 Apr 6.

PMID:
30967319
2.

O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.

Efimova EV, Appelbe OK, Ricco N, Lee SS, Liu Y, Wolfgeher DJ, Collins TN, Flor AC, Ramamurthy A, Warrington S, Bindokas VP, Kron SJ.

Mol Cancer Res. 2019 Jun;17(6):1338-1350. doi: 10.1158/1541-7786.MCR-18-1025. Epub 2019 Mar 18.

PMID:
30885991
3.

Erratum for Rhee et al., "Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants".

Rhee EG, Rizk ML, Calder N, Nefliu M, Warrington SJ, Schwartz MS, Mangin E, Boundy K, Bhagunde P, Colon-Gonzalez F, Jumes P, Liu Y, Butterton JR.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e02197-18. doi: 10.1128/AAC.02197-18. Print 2018 Dec. No abstract available.

4.

Rapid Disruption of Dishevelled Activity Uncovers an Intercellular Role in Maintenance of Prickle in Core Planar Polarity Protein Complexes.

Ressurreição M, Warrington S, Strutt D.

Cell Rep. 2018 Nov 6;25(6):1415-1424.e6. doi: 10.1016/j.celrep.2018.10.039.

5.

Evaluation of IV to Enteral Benzodiazepine Conversion Calculations in a Pediatric Intensive Care Setting.

Warrington SE, Collier HK, Himebauch AS, Wolfe HA.

Pediatr Crit Care Med. 2018 Nov;19(11):e569-e575. doi: 10.1097/PCC.0000000000001687.

PMID:
30080777
6.

Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers.

Adeloye T, Sahgal O, Puri A, Warrington S, Endo T, Dennison J, Johnston A.

Clin Pharmacol Drug Dev. 2018 Nov;7(8):844-859. doi: 10.1002/cpdd.586. Epub 2018 Jul 25.

7.

Physiology, Catecholamines.

Paravati S, Warrington SJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 5.

8.

Tetrodotoxin Toxicity.

Kotipoyina HR, Warrington SJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Feb 4.

9.

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants.

Rhee EG, Rizk ML, Calder N, Nefliu M, Warrington SJ, Schwartz MS, Mangin E, Boundy K, Bhagunde P, Colon-Gonzalez F, Jumes P, Liu Y, Butterton JR.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00280-18. doi: 10.1128/AAC.00280-18. Print 2018 Sep. Erratum in: Antimicrob Agents Chemother. 2018 Nov 26;62(12):.

10.

Amenamevir: Studies of Potential CYP2C8- and CYP2B6-Mediated Pharmacokinetic Interactions With Montelukast and Bupropion in Healthy Volunteers.

Dennison J, Puri A, Warrington S, Endo T, Adeloye T, Johnston A.

Clin Pharmacol Drug Dev. 2018 Nov;7(8):860-870. doi: 10.1002/cpdd.578. Epub 2018 Jun 5.

11.

A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers.

Jansen M, Warrington S, Dishy V, Ohwada S, Johnson L, Brown K, Ishizuka H.

Clin Pharmacol Drug Dev. 2018 Aug;7(6):661-669. doi: 10.1002/cpdd.448. Epub 2018 Apr 17.

PMID:
29663714
12.

Preclinical to Human Translational Pharmacology of the Novel M1 Positive Allosteric Modulator MK-7622.

Uslaner JM, Kuduk SD, Wittmann M, Lange HS, Fox SV, Min C, Pajkovic N, Harris D, Cilissen C, Mahon C, Mostoller K, Warrington S, Beshore DC.

J Pharmacol Exp Ther. 2018 Jun;365(3):556-566. doi: 10.1124/jpet.117.245894. Epub 2018 Mar 21.

PMID:
29563325
13.

Bacterial DNA Mutations.

Watford S, Warrington SJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Apr 27.

14.

A Dual Function for Prickle in Regulating Frizzled Stability during Feedback-Dependent Amplification of Planar Polarity.

Warrington SJ, Strutt H, Fisher KH, Strutt D.

Curr Biol. 2017 Sep 25;27(18):2784-2797.e3. doi: 10.1016/j.cub.2017.08.016. Epub 2017 Sep 14.

15.

Rabies.

Koury R, Warrington SJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2018 Nov 18.

16.

Shellfish Allergy.

Alonso LL, Warrington SJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2018 Dec 14.

17.

Radiation Syndrome.

Acosta R, Warrington SJ.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Jan 20.

18.

Cardiac Trauma.

Warrington SJ, Mahajan K.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Jul 30.

19.

Inter-rater Agreement of End-of-shift Evaluations Based on a Single Encounter.

Warrington S, Beeson M, Bradford A.

West J Emerg Med. 2017 Apr;18(3):518-524. doi: 10.5811/westjem.2016.12.32014. Epub 2017 Mar 7.

20.

Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.

Boyce M, van den Berg F, Mitchell T, Darwin K, Warrington S.

Eur J Clin Pharmacol. 2017 Jul;73(7):925. doi: 10.1007/s00228-017-2241-3. Epub 2017 Apr 1. No abstract available.

PMID:
28365794
21.

Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab/Humira, in healthy subjects.

Puri A, Niewiarowski A, Arai Y, Nomura H, Baird M, Dalrymple I, Warrington S, Boyce M.

Br J Clin Pharmacol. 2017 Jul;83(7):1405-1415. doi: 10.1111/bcp.13245. Epub 2017 Mar 9.

22.

Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.

Boyce M, van den Berg F, Mitchell T, Darwin K, Warrington S.

Eur J Clin Pharmacol. 2017 Feb;73(2):129-139. doi: 10.1007/s00228-016-2150-x. Epub 2016 Oct 29.

PMID:
27796466
23.

Unusual case of dyspnea in a child.

Warrington S, Jeyakumar A.

Ear Nose Throat J. 2016 Oct-Nov;95(10-11):442-443. No abstract available.

PMID:
27792820
24.

Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers.

Pawsey S, Wood M, Browne H, Donaldson K, Christie M, Warrington S.

Drugs R D. 2016 Jun;16(2):181-91. doi: 10.1007/s40268-016-0127-y.

25.

Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects.

Boyce M, Warrington S, Cortezi B, Zöllner S, Vauléon S, Swinkels DW, Summo L, Schwoebel F, Riecke K.

Br J Pharmacol. 2016 May;173(10):1580-8. doi: 10.1111/bph.13433. Epub 2016 Apr 8.

26.

Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers.

Norris V, Warrington S, Boyce M.

J Interferon Cytokine Res. 2016 Feb;36(2):113-9. doi: 10.1089/jir.2014.0231. Epub 2015 Dec 21.

PMID:
26692052
27.

The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions.

Jurcevic S, Humfrey C, Uddin M, Warrington S, Larsson B, Keen C.

Br J Clin Pharmacol. 2015 Dec;80(6):1324-36. doi: 10.1111/bcp.12724. Epub 2015 Oct 2.

28.

Identification of Burkholderia pseudomallei Near-Neighbor Species in the Northern Territory of Australia.

Ginther JL, Mayo M, Warrington SD, Kaestli M, Mullins T, Wagner DM, Currie BJ, Tuanyok A, Keim P.

PLoS Negl Trop Dis. 2015 Jun 29;9(6):e0003892. doi: 10.1371/journal.pntd.0003892. eCollection 2015.

29.

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects.

Jenkins H, Sakurai Y, Nishimura A, Okamoto H, Hibberd M, Jenkins R, Yoneyama T, Ashida K, Ogama Y, Warrington S.

Aliment Pharmacol Ther. 2015 Apr;41(7):636-48. doi: 10.1111/apt.13121. Epub 2015 Feb 23.

30.

Pharmacokinetics, pharmacodynamics and food effect of LB30870, a novel direct thrombin inhibitor, after single oral doses in healthy men.

Kim J, Lee SH, Boyce M, Warrington S, Cho KH, Yoon SK, Park HD, Kim A.

Xenobiotica. 2015;45(8):663-71. doi: 10.3109/00498254.2015.1010110. Epub 2015 Feb 12.

PMID:
25673087
31.

Benefits and costs of ecological restoration: Rapid assessment of changing ecosystem service values at a U.K. wetland.

Peh KS, Balmford A, Field RH, Lamb A, Birch JC, Bradbury RB, Brown C, Butchart SH, Lester M, Morrison R, Sedgwick I, Soans C, Stattersfield AJ, Stroh PA, Swetnam RD, Thomas DH, Walpole M, Warrington S, Hughes FM.

Ecol Evol. 2014 Oct;4(20):3875-86. doi: 10.1002/ece3.1248. Epub 2014 Sep 23.

32.

Entrustable professional activities: making sense of the emergency medicine milestones.

Beeson MS, Warrington S, Bradford-Saffles A, Hart D.

J Emerg Med. 2014 Oct;47(4):441-52. doi: 10.1016/j.jemermed.2014.06.014. Epub 2014 Aug 7.

PMID:
25124138
33.

A novel peptide-based pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety.

Francis JN, Bunce CJ, Horlock C, Watson JM, Warrington SJ, Georges B, Brown CB.

Vaccine. 2015 Jan 3;33(2):396-402. doi: 10.1016/j.vaccine.2014.06.006. Epub 2014 Jun 10.

34.

Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.

Ford J, Lawson M, Fowler D, Maruyama N, Mito S, Tomiyasu K, Kinoshita S, Suzuki C, Kawaguchi A, Round P, Boyce M, Warrington S, Weber W, van Deventer S, Kastelein JJ.

Br J Clin Pharmacol. 2014 Sep;78(3):498-508. doi: 10.1111/bcp.12380.

35.

Incidence of maternal sensitisation to Rh(D) in Christchurch, New Zealand and reasons for prophylaxis failures.

Badami KG, Parker J, Kenny A, Warrington S.

N Z Med J. 2014 Jan 24;127(1388):40-6.

PMID:
24481385
36.

[Ru(η5-C5H5)(η6-C10H8)]PF6 as a catalyst precursor for the one-pot direct C-H alkenylation of nitrogen heterocycles.

Lynam JM, Milner LM, Mistry NS, Slattery JM, Warrington SR, Whitwood AC.

Dalton Trans. 2014 Mar 21;43(11):4565-72. doi: 10.1039/c3dt52984c.

PMID:
24481140
37.

Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, Munisamy M, Falzone R, Harrop J, Cehelsky J, Bettencourt BR, Geissler M, Butler JS, Sehgal A, Meyers RE, Chen Q, Borland T, Hutabarat RM, Clausen VA, Alvarez R, Fitzgerald K, Gamba-Vitalo C, Nochur SV, Vaishnaw AK, Sah DW, Gollob JA, Suhr OB.

N Engl J Med. 2013 Aug 29;369(9):819-29. doi: 10.1056/NEJMoa1208760.

38.

Control of tissue morphology by Fasciclin III-mediated intercellular adhesion.

Wells RE, Barry JD, Warrington SJ, Cuhlmann S, Evans P, Huber W, Strutt D, Zeidler MP.

Development. 2013 Sep;140(18):3858-68. doi: 10.1242/dev.096214. Epub 2013 Aug 14.

39.

Survey of users of TOPS, an internet-based system to prevent healthy subjects from over-volunteering for clinical trials.

Boyce M, Walther M, Kirk J, Smith S, Warrington S.

Eur J Clin Pharmacol. 2013 Oct;69(10):1757-60. doi: 10.1007/s00228-013-1534-4. Epub 2013 Jun 7.

PMID:
23743779
40.

A microdose study of ¹⁴C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung.

Lappin G, Boyce MJ, Matzow T, Lociuro S, Seymour M, Warrington SJ.

Eur J Clin Pharmacol. 2013 Sep;69(9):1673-82. doi: 10.1007/s00228-013-1528-2. Epub 2013 Jun 6.

PMID:
23739997
41.

Are Simulation Stethoscopes a Useful Adjunct for Emergency Residents' Training on High-fidelity Mannequins?

Warrington SJ, Beeson MS, Fire FL.

West J Emerg Med. 2013 May;14(3):275-7. doi: 10.5811/westjem.2012.8.12519.

42.

Giving monoclonal antibodies to healthy volunteers in phase 1 trials: is it safe?

Tranter E, Peters G, Boyce M, Warrington S.

Br J Clin Pharmacol. 2013 Aug;76(2):164-72. doi: 10.1111/bcp.12096. Review.

43.
44.
45.

The Frizzled-dependent planar polarity pathway locally promotes E-cadherin turnover via recruitment of RhoGEF2.

Warrington SJ, Strutt H, Strutt D.

Development. 2013 Mar;140(5):1045-54. doi: 10.1242/dev.088724. Epub 2013 Jan 30.

46.

Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species.

Stone JK, Mayo M, Grasso SA, Ginther JL, Warrington SD, Allender CJ, Doyle A, Georgia S, Kaestli M, Broomall SM, Karavis MA, Insalaco JM, Hubbard KS, McNew LA, Gibbons HS, Currie BJ, Keim P, Tuanyok A.

BMC Microbiol. 2012 Nov 5;12:250. doi: 10.1186/1471-2180-12-250.

47.

Pharmacokinetics and metabolism of [14C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans.

Furuta S, Smart C, Hackett A, Benning R, Warrington S.

Xenobiotica. 2013 May;43(5):432-42. doi: 10.3109/00498254.2012.731618. Epub 2012 Oct 18.

PMID:
23075005
48.

TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials.

Boyce M, Walther M, Nentwich H, Kirk J, Smith S, Warrington S.

Eur J Clin Pharmacol. 2013 Mar;69(3):731. doi: 10.1007/s00228-012-1351-1. Epub 2012 Sep 12. No abstract available.

PMID:
22968810
49.

Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men.

Scott G, Ahmad I, Howard K, MacLean D, Oliva C, Warrington S, Wilbraham D, Worthington P.

Br J Clin Pharmacol. 2013 Feb;75(2):381-91. doi: 10.1111/j.1365-2125.2012.04385.x.

50.

Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects.

Boyce M, David O, Darwin K, Mitchell T, Johnston A, Warrington S.

Aliment Pharmacol Ther. 2012 Jul;36(2):181-9. doi: 10.1111/j.1365-2036.2012.05143.x. Epub 2012 May 20.

Supplemental Content

Loading ...
Support Center